CALCIMEDICA INC Stock Prediction
AI-powered sentiment analysis and prediction trends for CALC, updated each market day.
CALC AI Sentiment
AI sees no strong directional signal for CALCIMEDICA INC stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About CALCIMEDICA INC
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
Sector
Exchange
Market Cap
$10,249,289
Cap Tier
Employees
16
Headquarters
LA JOLLA, CA
Listed Since
Sept. 25, 2020
Website
CALC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CALC Volatility
CALCIMEDICA INC has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
